-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
aTYR PHARMA INC quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
- aTYR PHARMA INC Operating Income (Loss) for the quarter ending June 30, 2024 was -$17.3M, a 27.7% decline year-over-year.
- aTYR PHARMA INC Operating Income (Loss) for the twelve months ending June 30, 2024 was -$62.5M, a 30.8% decline year-over-year.
- aTYR PHARMA INC annual Operating Income (Loss) for 2023 was -$54.9M, a 18.4% decline from 2022.
- aTYR PHARMA INC annual Operating Income (Loss) for 2022 was -$46.4M, a 36.4% decline from 2021.
- aTYR PHARMA INC annual Operating Income (Loss) for 2021 was -$34M, a 114% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)